当前位置:APASL-en-亚太肝脏研究协会年会 >> 正文
[APASL2014]Public Health Insurance and Treatment Costs Among Hepatitis B Related Diseases
—— 作者:Y.H.Che 时间:2014-03-24
阅读数:
141
简介:Over half a million Chinese people die annually from end-stage complications associated with chronic liver disease caused by the hepatitis B virus (HBV). In fact, HBV-related diseases are the leading cause of chronic liver disease in China. Over half a million people in China die each year from end-stage complications related to the disease and, most often, these are associated with staggering health care costs and socioeconomic burdens.
请登录后查看详细内容
标签:
摘要赏析
摘要赏析
乙肝
发表评论
全部评论